NCT01603758View on ClinicalTrials.gov

Physiological Study of Human Cholesterol Metabolism and Excretion

PHASE1CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Coronary Heart DiseaseCardiovascular DiseaseDyslipidemiaDisorder of Cholesterol Metabolism
Interventions
DRUG

Ezetimibe

Ezetimibe 10 mg/day or placebo will be given for 6 weeks

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Richard E. Ostlund Jr., MD

OTHER

NCT01603758 - Physiological Study of Human Cholesterol Metabolism and Excretion | Biotech Hunter | Biotech Hunter